Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.10.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Aug. 31, 2018
Aug. 31, 2017
Current    
Cash $ 1,727,184 $ 2,533,337
Marketable Securities (Note 20) 10,151  
Accounts and other receivable (Note 7) 265,751 45,293
Inventory (Note 8) 87,233 67,174
Prepaid expenses and deposit (Note 18) 193,732 149,691
Total Current Assets 2,284,051 2,795,495
Patent (Note 9) 146,538 62,827
Equipment (Net) 1,237 1,856
Total Noncurrent Assets 147,775 64,683
TOTAL ASSETS 2,431,826 2,860,178
Current    
Accounts payable and accrued liabilities 35,785 32,574
Unearned revenue (Note 11) 0 17,083
Due to related parties (Note 15) 7,855 42,690
Total Current Liabilities 43,640 92,347
TOTAL LIABILITIES 43,640 92,347
STOCKHOLDERS' EQUITY    
Share Capital (Note 12) : Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Issued and outstanding: 75,533,471 common shares at August 31, 2018 and 67,975,761 common shares at August 31, 2017 75,533 67,976
Additional paid-in capital (Note 12) 22,095,682 16,108,270
Accumulated Other Comprehensive Income (14,247)  
Deficit (19,768,782) (13,169,939)
Equity attributable to shareholders of the Company 2,388,186 3,006,307
Non-Controlling Interest (Note 9)   (238,476)
Total Stockholders' Equity 2,388,186 2,767,831
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 2,431,826 $ 2,860,178